Logan et al, The Lancet, vol. 340, Jul. 25, 1992 Abstract Drug Thev Boll 1991, 29; 26 reference (see foot note #9). |
Chemical Abstracts 104:203737 j (1986). |
Chemical Abstracts 106:182648l (1987). |
P. Unge, et al. "Does Omeprazole, 40 mg o.m. improve antimicrobial therapy directed towards gastric Campylobacter-pylori in patients . . . " Scandinavian Journal of Gastroenterology 1989, 24 (Suppl. 166) p. 184 (ABSTRACT). |
P. Unge, et al. "Does Omeprazole improve antimicrobial therapy directed towards gastric Campylobacter-pylori in patients with antral gastritis" Scandinavian Journal of Gastroenterology 1989, 24 (Suppl. 167) p. 49-54 (ARTICLE). |
"Which regimen for H pylori eradication?" SCRIP No. 1861 Oct. 5, 1983, p. 23. |
S. Rune, "Helicobacter pylori, Peptic Ulcer Disease and Inhibition of Gastric Acid Secretion" Digestion 1992; 51 (Suppl. 1): 11-16. |
McDermott, et al., Science, The Absorption of Orally Administered Penicillin, Mar. 22, 1946, pp. 359-361. |
McNulty, et al., Eur. J. Clin. Microbiol. Infect. Dis., Susceptibility of Clinical Isolates, Aug., 1988, pp. 566-569. |
The Lancet, Clarithromycin and Omeprazole, vol. 340, Jul. 25, 1992. |
Goodwin, Worsley, Peptic Ulcer Disease, 1992, Current Science, 8:122-127. |
Loo, Sherman, Matlow; Helicobacter pylori Infection, Anti-microbial Agents & Chemotherapy, May, 1992, pp. 1133-1135. |